Douglas Flora: How Science Turned a Stage IV Lung Cancer Diagnosis Into 12 Years of Hope
Oncologist Douglas Flora shares the story of a patient who has survived stage IV lung cancer for 12 years due to targeted genomic therapy. He emphasizes that advancements in precision medicine are transforming terminal diagnoses into manageable conditions.
Why it matters
It highlights the shift in oncology from generalized treatments to personalized, mutation-specific therapies that significantly improve patient outcomes.
Douglas Flora , President-Elect at Association of Cancer Care Centers, shared on LinkedIn :
‘Nothing in life is to be feared; it is only to be understood. Now is the time to understand more, so that we may fear less.’ -Marie Curie.
I say a version of this sentence to nearly every patient who sits across from me with a new diagnosis: There has never been a better day to have cancer than today, and tomorrow will be better than this one.
August 1 was World Lung Cancer Day . With her blessing, I want to share my friend Michelle’s story.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in